Inhalation Sciences: close to 200 register for latest expert s webinar - now available online Almost 200 specialists registered for ISAB s latest experts webinar, now. | May 4, 2023
Transaction enables Neuraxpharm to further focus on its core CNS therapeutic area and for Inke to accelerate its development as an independent entity BARCELONA, Spain, DÜSSELDORF, Germany
Results from the EXPEDITE study of Remodulin® induction prior to Orenitram® therapy to be presented at ATS
Baseline patient data from the TETON studies of Tyvaso® Inhalation Solution in. | April 18, 2023